Company Overview
- Headquarters
- 35 CambridgePark Drive 4th Floor, Cambridge MA
- Website
- syros.com
- xd****@syros.com
- Phone
- (617) 744-1340
- Employees
- 107
- Founded in
- 2012
- Industry
- Materials/Manufacturing
- Stock Symbol
- NASDAQ:SYR
- NAICS Code
-
NAICS Code 62151 CompaniesNAICS Code 541711 CompaniesNAICS Code 5417 CompaniesNAICS Code 6215 CompaniesNAICS Code 621 CompaniesNAICS Code 54 CompaniesNAICS Code 62 CompaniesNAICS Code 54171 CompaniesNAICS Code 541 Companies
- SIC Code
-
SIC Code 37 CompaniesSIC Code 372 Companies
Financials & Stats
Revenue
$2B
Total Funding Amount
$480M
Who is Syros Pharmaceuticals
Syros Pharmaceuticals is a company based in Cambridge, Massachusetts, with 107 employees. Syros Pharmaceuticals focuses on developing treatments for hematologic malignancies, specifically targeting blood disorders that haven't responded well to other treatments. Their current focus is on developing tamibarotene, an oral selective RARα agonist, for patients with higher-risk myelodysplastic syndrome and acute myeloid leukemia with RARA gene overexpression. The company emphasizes a commitment to developing innovative therapies that set new standards of care for patients with these challenging conditions. For more information about Syros Pharmaceuticals and their work, please visit their website at www.syros.com, or follow them on Twitter (@SyrosPharma) or LinkedIn.
Company Leadership
Syros Pharmaceuticals Industry Tags
Syros Pharmaceuticals Tech Stack
Companies Similar to Syros Pharmaceuticals
Analyze industry trends and opportunities by examining competitors and companies comparable to Syros Pharmaceuticals, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 2M | 3 | Layton, UT | ||
| 2M | 11 | Woburn, MA | 2002 | |
| 2M | 9 | 2010 | ||
| 2M | 161 | 1985 | ||
| 2M | 29 | 1020 Renens, CT | 1957 |